Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Am J Prev Med. 2014 Aug 15;47(4):375–381. doi: 10.1016/j.amepre.2014.05.012

Table 2.

Positive detection rates by screening eligibility criteria, weighted national estimates

%Eligible %Positive NNS Cost per 1 positive test Positive tests, n Potentially missed cases, n % Positive tests missed
Age ≥18 years
 Universal screening 100% 5.0% 20 $91.11 9,598,214
 ADA guideline 80% 6.0% 17 $75.47 9,292,119 306,095 3.2%
 USPSTF guideline 26% 7.4% 14 $61.36 3,717,445 5,880,770 61.3%
Age ≥35 years
 Universal screening 100% 6.8% 15 $66.37 9,075,042
 ADA guideline 91% 7.3% 14 $62.10 8,868,586 206,455 2.3%
 USPSTF guideline 34% 8.0% 12 $56.58 3,566,877 5,508,164 60.7%
Age 18–34 years
 Universal screening 100% 0.9% 115 $520.27 523,173
 ADA guideline 55% 1.3% 78 $355.42 423,533 99,640 19.0%
 USPSTF guideline 10% 2.6% 38 $174.54 150,567 372,606 71.2%
Age 35–44 years
 Universal screening 100% 3.6% 28 $127.07 1,374,725
 ADA guideline 71% 4.3% 23 $105.42 1,168,270 206,455 15.0%
 USPSTF guideline 25% 6.8% 15 $67.13 662,145 712,580 51.8%
Age ≥45 years
 Universal screening 100% 8.2% 12 $55.53 7,700,317
 ADA guideline 100% 8.2% 12 $55.53 7,700,317
 USPSTF guideline 37% 8.4% 12 $54.17 2,904,732 4,795,585 62.3%

ADA, American Diabetes Association; NNS, number needed to screen; USPSTF, U.S. Preventive Services Task Force